Palisade Bio Inc. (NASDAQ: PALI) Stock Information | RedChip

Palisade Bio Inc. (NASDAQ: PALI) Listen to this Section


$3.94
+0.2250 ( +6.07% ) 19.2K

Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.

Market Data


Open


$3.94

Previous close


$3.71

Volume


19.2K

Market cap


$3.69M

Day range


$3.53 - $3.95

52 week range


$3.30 - $28.95

Insider Ownership Transactions

Total Amount Purchased: -25,968.00 | $ -102,184.08

Date Type Amount Purchased Purchaser
2024-02-01 Buy 10000.00 Finley John David
2024-02-01 Buy 10000.00 Williams Donald Allen
2024-01-05 Sale -1309.00 Finley John David
2023-12-19 Sale -5559.00 Finley John David
2023-11-24 Sale -5820.00 GRAY MARY ANN
2023-11-24 Sale -5820.00 Neal James R
2023-11-24 Sale -10000.00 Finley John David
2023-11-24 Sale -5820.00 Csimma Cristina
2023-11-24 Sale -5820.00 Wei Binxian
2023-11-24 Sale -5820.00 Diaz Stephanie

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 43 Apr 10, 2024
8-k 8K-related 16 Apr 05, 2024
8-k 8K-related 15 Mar 27, 2024
10-k Annual reports 74 Mar 26, 2024
4 Insider transactions 1 Mar 12, 2024
8-k 8K-related 15 Mar 06, 2024
8-k 8K-related 16 Feb 13, 2024
4 Insider transactions 1 Feb 13, 2024
4 Insider transactions 1 Feb 13, 2024
4 Insider transactions 1 Feb 13, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.